MOVING SCIENCE FORWARD
MultiPark is a strategic research area funded by the Swedish Government. Building on the strong tradition of cutting-edge research on Parkinson’s disease at Lund University, our vision is to create new and innovative strategies for improved and novel treatments, disease modifications and eventually cures for neurodegenerative diseases, in order to improve the quality of life for people living and ageing with such disorders.
In the retail business, the term G-force is routinely used to promote “hi-tech” products, whether it be racing gear, clothing or watches with uniquely durable qualities. In May of this year, a group of Parkinson’s researchers chose that same name for a global alliance with real technological prowess.
A major breakthrough in the development of stem cell-derived brain cells has put MultiPark-researchers on a firm path towards the first ever stem cell transplantations in people with Parkinson’s disease. A new study presents the next generation of transplantable dopamine neurons produced from stem cells. These cells carry the same properties as the dopamine neurons found in the human brain.
Parkinson's disease is strongly linked to the degeneration of the brain’s movement center. In the last decade, the question of where the disease begins has led researchers to a different part of the human anatomy. In 2003, the German neuropathologist Heiko Braak presented a theory suggesting that the disease begins in the gut and spreads to the brain. The idea has since, despite vocal critics, gained a lot of ground. Researchers from MultiPark at Lund University now present the first direct evidence that the disease can actually migrate from the gut to the brain.
In the future, people who worry about being affected by Alzheimer's disease could get an answer with the help of a simple test. Such a test could put people at ease who belong to the low risk population, and help those at risk to keep their thinking skills intact as long as possible.
- This is the first study to show that the test works in everyday clinical practice, says MultiPark's Oskar Hansson, associate professor at the Department of Clinical Memory Research at Lund University and senior physician at Skåne University Hospital.
MultiPark's Sara Snogerup Linse was today named this year's recipient of the KTH Royal Institute of Technology’s Great Prize and SEK 1.2 million. The award places her in the same company as Robyn, Hans Rosling och Niklas Zennström.